A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

Pfeffer, M.A. et al. (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. New England Journal of Medicine, 361(21), pp. 2019-2032. (doi:10.1056/NEJMoa0907845)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Cooper, Dr Mark and McMurray, Professor John
Authors: Pfeffer, M.A., Burdmann, E.A., Chen, C.Y., Cooper, M.A., Cooper, M.J., de Zeeuw, D., Eckardt, K.U., Feyzi, J.M., Ivanovich, P., Kewalramani, R., Levey, A.S., Lewis, E.F., Mcgill, J.B., McMurray, J.J., Parfrey, P., Parving, H.H., Remuzzi, G., Singh, A.K., Solomon, S.D., and Toto, R.
College/School:College of Medical Veterinary and Life Sciences
College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:New England Journal of Medicine
Publisher:Massachusetts Medical Society
ISSN:0028-4793
ISSN (Online):1533-4406

University Staff: Request a correction | Enlighten Editors: Update this record